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The characterization of perphenazine and scopolamine aerosols generated using 
the capillary aerosol generator (CAG) was reported. Variables including steady state 
power, the formulation vehicle, the drug concentration and the formulation flow rate 
were studied for their effects on the chemical stability and particle size of these drug 
aerosols. 
Stability-indicating HPLC and LC-MS assays were developed and validated for 
perphenazine and scopolamine, respectively. The chemical stability of each compound 
xxv 
was investigated under a variety of stress conditions and the structure of degradation 
products was proposed. 
Perphenazine aerosols were generated fi-om propylene glycol (PG) formulations 
with concentrations of 9, 48 and 90mM at formulation flow rates of 2.5 and 5.OyLls at a 
series of steady state powers. At higher aerosolization powers, the low concentration 
formulation (9mM) degraded with dehalogenation being the major pathway. The size of 
perphenazine aerosols was between 0.4 to 0.6pm. Changing the solute concentration 
produced only small changes (-0.2pm) in perphenazine aerosol particle size. The 
formulation flow rate did not significantly affect the aerosol size. 
Scopolamine degraded significantly when aerosolized in PG formulations. It 
was possible to generate chemically stable scopolamine aerosols fiom ethanol 
formulations. Significant amounts of degradation products were formed only at or 
above 4.6W at 5.OyLIs. Hydrolysis and dehydration appeared to be the major 
degradation pathways at higher powers and low formulation flow rate. The MMAD of 
scopolamine aerosols was between 0.5 and 2.Opm fi-om 8,20 and 40mM formulations at 
5.0 and 10.0yLIs. The size of scopolamine aerosols increased as a function of increasing 
the solute concentration. Increasing the formulation flow rate increased the linear 
velocity of the spray, thus the Reynolds number was increased and smaller particles 
were generated. 




































































































































































































































